BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33844766)

  • 1. [Cannabis use among hospitalized young people experiencing a first episode of psychosis: a case control study].
    Castañeda CP; Alliende LM; Iruretagoyena B; Nachar R; Mancilla F; Díaz C; Gallardo C; Mena C; Ramírez-Mahaluf JP; Undurraga J; González-Valderrama A; Crossley NA
    Rev Med Chil; 2020 Nov; 148(11):1606-1613. PubMed ID: 33844766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of sex on substance use between first episode psychosis patients and healthy people.
    Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
    Compr Psychiatry; 2016 Aug; 69():169-78. PubMed ID: 27423358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.
    Di Forti M; Marconi A; Carra E; Fraietta S; Trotta A; Bonomo M; Bianconi F; Gardner-Sood P; O'Connor J; Russo M; Stilo SA; Marques TR; Mondelli V; Dazzan P; Pariante C; David AS; Gaughran F; Atakan Z; Iyegbe C; Powell J; Morgan C; Lynskey M; Murray RM
    Lancet Psychiatry; 2015 Mar; 2(3):233-8. PubMed ID: 26359901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study.
    Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Ajnakina O; Gayer-Anderson C; Colizzi M; Quattrone D; Behlke I; Shetty S; McGuire P; David AS; Murray R; Bhattacharyya S
    Lancet Psychiatry; 2016 Oct; 3(10):947-953. PubMed ID: 27567467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-morbid Conduct Disorder symptoms are associated with cannabis use among individuals with a first episode of psychosis.
    Malcolm CP; Picchioni MM; DiForti M; Sugranyes G; Cooke E; Joseph C; McQueen G; Paparelli A; Stilo S; O'Connor J; Morgan C; Murray RM; Hodgins S
    Schizophr Res; 2011 Mar; 126(1-3):81-6. PubMed ID: 21186097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal relationship of first-episode non-affective psychosis with cannabis use: a clinical verification of an epidemiological hypothesis.
    Barrigón ML; Gurpegui M; Ruiz-Veguilla M; Diaz FJ; Anguita M; Sarramea F; Cervilla J
    J Psychiatr Res; 2010 May; 44(7):413-20. PubMed ID: 19900684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis use in first episode psychosis: Meta-analysis of prevalence, and the time course of initiation and continued use.
    Myles H; Myles N; Large M
    Aust N Z J Psychiatry; 2016 Mar; 50(3):208-19. PubMed ID: 26286531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.
    Mané A; Fernández-Expósito M; Bergé D; Gómez-Pérez L; Sabaté A; Toll A; Diaz L; Diez-Aja C; Perez V
    Psychiatry Res; 2015 Sep; 229(1-2):70-4. PubMed ID: 26235479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis as a risk factor for psychosis: systematic review.
    Semple DM; McIntosh AM; Lawrie SM
    J Psychopharmacol; 2005 Mar; 19(2):187-94. PubMed ID: 15871146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
    Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
    Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in associations between cannabis and stimulant disorders in first admission psychosis.
    Sara G; Burgess P; Malhi GS; Whiteford H; Hall W
    Schizophr Res; 2013 Jul; 147(2-3):216-22. PubMed ID: 23684162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of comorbid cannabis use on outcome in first episode psychosis.
    Hadden KL; LeDrew K; Hogan K; Thomas B
    Early Interv Psychiatry; 2018 Oct; 12(5):848-855. PubMed ID: 27592556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS).
    Tosato S; Lasalvia A; Bonetto C; Mazzoncini R; Cristofalo D; De Santi K; Bertani M; Bissoli S; Lazzarotto L; Marrella G; Lamonaca D; Riolo R; Gardellin F; Urbani A; Tansella M; Ruggeri M;
    J Psychiatr Res; 2013 Apr; 47(4):438-44. PubMed ID: 23290558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor structure of the Cannabis Experiences Questionnaire in a first-episode psychosis sample.
    Birnbaum ML; Cleary SD; Ramsay Wan C; Pauselli L; Compton MT
    Early Interv Psychiatry; 2019 Jun; 13(3):495-501. PubMed ID: 29052952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis and stimulant disorders and readmission 2 years after first-episode psychosis.
    Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
    Br J Psychiatry; 2014 Jun; 204(6):448-53. PubMed ID: 24578446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study.
    Spinazzola E; Quattrone D; Rodriguez V; Trotta G; Alameda L; Tripoli G; Gayer-Anderson C; Freeman TP; Johnson EC; Jongsma HE; Stilo S; La Cascia C; Ferraro L; La Barbera D; Lasalvia A; Tosato S; Tarricone I; D'Andrea G; Galatolo M; Tortelli A; Tagliabue I; Turco M; Pompili M; Selten JP; de Haan L; Rossi Menezes P; Del Ben CM; Santos JL; Arrojo M; Bobes J; Sanjuán J; Bernardo M; Arango C; Kirkbride JB; Jones PB; O'Donovan M; Rutten BP; Van Os J; Morgan C; Sham PC; Austin-Zimmerman I; Li Z; Vassos E; ; Murray RM; Di Forti M
    Psychol Med; 2023 Nov; 53(15):7418-7427. PubMed ID: 37129249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and cost-effectiveness of contingency management for cannabis use in early psychosis: the CIRCLE randomised clinical trial.
    Sheridan Rains L; Marston L; Hinton M; Marwaha S; Craig T; Fowler D; King M; Omar RZ; McCrone P; Spencer J; Taylor J; Colman S; Harder C; Gilbert E; Randhawa A; Labuschagne K; Jones C; Stefanidou T; Christoforou M; Craig M; Strang J; Weaver T; Johnson S
    BMC Med; 2019 Aug; 17(1):161. PubMed ID: 31412884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk-thresholds for the association between frequency of cannabis use and the development of psychosis: a systematic review and meta-analysis.
    Robinson T; Ali MU; Easterbrook B; Hall W; Jutras-Aswad D; Fischer B
    Psychol Med; 2023 Jul; 53(9):3858-3868. PubMed ID: 35321777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users.
    Di Forti M; Sallis H; Allegri F; Trotta A; Ferraro L; Stilo SA; Marconi A; La Cascia C; Reis Marques T; Pariante C; Dazzan P; Mondelli V; Paparelli A; Kolliakou A; Prata D; Gaughran F; David AS; Morgan C; Stahl D; Khondoker M; MacCabe JH; Murray RM
    Schizophr Bull; 2014 Nov; 40(6):1509-17. PubMed ID: 24345517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis use and anticipatory pleasure as reported by subjects with early psychosis and community controls.
    Cassidy CM; Lepage M; Harvey PO; Malla A
    Schizophr Res; 2012 May; 137(1-3):39-44. PubMed ID: 22436394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.